Skip to main content

Published locations for Atezolizumab + bevacizumab shows long-term benefits over sorafenib for unresectable HCC

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Atezolizumab + bevacizumab shows long-term benefits over sorafenib for unresectable HCC

User login

  • Reset your password
  • /content/atezolizumab-bevacizumab-shows-long-term-benefits-over-sorafenib-unresectable-hcc
  • /fedprac/article/250477/hepatocellular-carcinoma/atezolizumab-bevacizumab-shows-long-term-benefits